Search company, investor...

Mishka Therapeutics

Claim your profile to get in front of buyers, investors, and analysts.

Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Learn more.

Stage

Grant | Alive

Total Raised

$20K

Last Raised

$20K | 3 yrs ago

About Mishka Therapeutics

Mishka Therapeutics provides exosome-based therapeutics modeled after the exosomes secreted by hypothalamus stem cells that have been shown to increase lifespan in laboratory mice by 10%.

Headquarters Location

Livermore, California,

United States

Missing: Mishka Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Mishka Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Mishka Therapeutics Frequently Asked Questions (FAQ)

Where is Mishka Therapeutics's headquarters?
Mishka Therapeutics's headquarters is located at Livermore.
What is Mishka Therapeutics's latest funding round?
Mishka Therapeutics's latest funding round is Grant.
How much did Mishka Therapeutics raise?
Mishka Therapeutics raised a total of $20K.
Who are the investors of Mishka Therapeutics?
Investors of Mishka Therapeutics include Y Combinator.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.